Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants
Phase of Trial: Phase I
Latest Information Update: 23 Nov 2016
At a glance
- Drugs Apixaban (Primary) ; Clarithromycin
- Indications Venous thromboembolism
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 18 Nov 2016 Status changed from recruiting to completed.
- 06 Oct 2016 Status changed from not yet recruiting to recruiting.
- 30 Sep 2016 New trial record